Julie Clark - 30 Sep 2021 Form 4 Insider Report for Adverum Biotechnologies, Inc. (ADVM)

Role
Chief Medical Officer
Signature
Julie Clark, by /s/ Ron A. Metzger, Attorney-in-Fact.
Issuer symbol
ADVM
Transactions as of
30 Sep 2021
Net transactions value
-$10,342
Form type
4
Filing time
04 Oct 2021, 17:36:15 UTC
Previous filing
10 Aug 2021
SEC
View on sec.gov

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction ADVM Common Stock Sale $10,342 -4,766 -2.8% $2.17 164,723 30 Sep 2021 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were sold pursuant to an irrevocable election previously made by the Reporting Person to sell shares of common stock necessary to cover the federal, state and local tax withholding obligations, as well as related brokerage commission fees.